Comparison Chart ALK-Abelló A/S

ALK B

DK0061802139

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ALK-ABELLÓ A/S	Other Pharmaceuticals	-0.33%	-0.58%	+4.81%	+22.24%	+60.91%	8.12B

Real-time Estimate Cboe Europe Other stock markets 11:13:34 14/07/2026 BST			5-day change	1st Jan Change
239.90 ^DKK	-0.21%		-0.58%	+4.81%

06-15	ALK Receives UK Approval For EURneffy 1 Mg As The First And Only Needle-Free Adrenaline Treatment For Young Children At Risk Of Anaphylaxis	CI
06-15	UK Regulator OKs Lower Dose of ALK-Abelló's Severe Allergic Reaction Treatment	MT

Comparison Chart ALK-Abelló A/S

Stocks

ALK B

DK0061802139

Pharmaceuticals

Compared values